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Purpose: Our purpose is to describe a 60-year-old male, who has plateau iris conﬁguration and devel-
oped bilateral ciliochoroidal effusion syndrome after ingestion of acetazolamide.
Observations: Our case was a research participant in a multi-center clinical study (ClinicalTrials.gov
NCT01677507). During the course of this study, he was treated with a single dose of acetazolamide
(500 mg), and seven days later treated with latanoprost one drop daily at bedtime both eyes for seven
days, and then was administered another dose of acetazolamide (500 mg). Several hours later he
complained of blurred vision in the distance and mild headache. On examination, he had a myopic shift,
intraocular pressures of 36 mmHg in right eye and 35 mmHg in left eye, shallow anterior chambers both
eyes, and occluded angles by gonioscopy both eyes. An echographic exam conﬁrmed the bilateral cil-
iochoroidal effusion syndrome. He was treated by no further dosing of acetazolamide and started on
timolol, atropine and prednisolone. Two weeks later, the bilateral choroidal effusion and acute angle
closure were resolved. Repeat echography showed plateau iris conﬁguration.
Conclusions and Importance: To the best of our knowledge, drug-induced bilateral ciliochoroidal effusion
syndrome has not been reported with acetazolamide in plateau iris conﬁguration.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sulfonamide derivatives have been reported to be associated
with an idiosyncratic inﬂammation in the uveal tissues that result
in choroidal effusion and ciliary body edema. Such tissue edema
can cause forward displacement of the lens-ciliary body-iris com-
plex, shallow anterior chamber and angle closure, elevated IOP and
myopia shift [1e3]. The clinical consequences of this idiosyncratic
reaction in uveal tissues was termed as ciliochoroidal effusion
syndrome in 2002 when ophthalmologists were trying to illustrate
the pathomechanism of topiramate-inducedmyopic shift and acute
angle closure [4]. The ciliochoroidal effusion syndrome can occur
days or weeks after drug administration [3] and the deﬁnitive
treatment is to discontinue the causative medication. Early caselmology and Visual Sciences,
n), raquellcosta@hotmail.com
s), smoroi@med.umich.edu
access article under the CC BY-NCreports about bilateral choroidal effusion and acute angle closure
were most commonly associated with the use of topiramate [2].
There have been a few bilateral cases reported after acetazolamide
following monocular cataract surgery [3,5e8]. We present a case of
bilateral ciliochoroidal effusion syndrome after exposure to acet-
azolamide in a subject with plateau iris conﬁguration, normal lens,
and without any surgery.2. Case report
We report a research subject who was part of a clinical research
study (ClinicalTrials.gov NCT01677507). The patient provided
written consent for publication of this report. A 60-year-old male,
with previous healthy eyes, was participating in multi-center
clinical study. As part of the protocol, he was exposed to 500 mg
of acetazolamide. One week later, he started taking latanoprost in
each eye daily at bedtime for seven days. Afterwards, he was
administrated another dose of acetazolamide, and several hours
later he noted blurred vision and headache. He reported no history-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cations included over the counter supplements.
His initial examination before the ﬁrst acetazolamide adminis-
tration showed uncorrected visual acuity of 20/15 in the right eye
and 20/15-1 in the left eye. His right IOP was 14 mmHg and left IOP
was 11 mmHg. His anterior chamber was deep and quiet in both
eyes. His iris showed central transilumination defects and lens had
trace nuclear sclerosis in both eyes. Fundus examwere both normal
with vertical cup-to-disc ratios of 0.1. Gonioscopy showed open
angle in all quadrants with mild pigment in trabecular meshwork
and no classic “double hump” sign.
After his second ingestion of acetazolamide, his visual acuity
decreased to 20/25 in the right eye with manifest refraction to 20/
15 with minus 0.50 sphere diopters, and 20/15 in the left eye. His
IOPs were 36 mmHg in right eye and 35 mmHg in left eye. He had
very shallow anterior chambers with iris touch in the peripheral
cornea and iris draping over the lens in both eyes. Gonioscopy
showed occluded angle both eyes. Fundus exam showed no
choroidal folds. Physical examination of his body showed no rash,
and he denied urticaria and any breathing difﬁculties.
Echography exam with high frequency (50 MHz) ultrasound
biomicroscopy (UBM) showed bilateral shallow anterior chambers
with anterior chamber depth (ACD) measurements of 1.68 mm in
right eye and 1.63 mm in left eye (Fig. 1A). Other UBM ﬁndings
included 360 of anterior rotation of the ciliary body with angle
closure and ciliochoroidal detachment in both eyes (Fig. 1B). B-scan
ﬁndings included 360 shallow choroidal effusions in the posterior
segment, with the highest elevation being nasally were found in
both eyes (Fig. 1C).Fig. 1. Echography of ciliochoroidal effusion syndrome. Ultrasound biomicroscopy (UBM) sh
closure (B). B-scan demonstrated 360 shallow choroidal effusions in the posterior segment
anterior chamber and open angle (D) and plateau iris conﬁguration with anterior rotation
shallow posterior choroidal effusion (F).Based on the history, clinical exam and ultrasound ﬁndings, the
diagnosis of ciliochoroidal effusion syndrome with myopic shift
and acute angle closure after acetazolamide was determined. The
treatment included no further use of acetazolamide and latano-
prost, and withdrawal from the clinical study. To manage his IOP
and choroidal effusions, timolol 0.5% one drop bid, prednisolone 1%
one drop qid and atropine 1% one drop bid were prescribed to both
eyes.
After two weeks, all of the clinical ﬁndings and his symptoms
resolved. His visual acuity was 20/15 in right and 20/20 in left. His
IOPs were 12 mmHg in right and 11 mmHg in left. His anterior
chambers were comparable to his baseline examination and were
deep and quiet in both eyes. His ACD was deeper (Fig. 1D) with
measurements of 2.16 mm in right and 2.3 mm in left. Repeat UBM
showed plateau iris conﬁguration with anterior rotation of the
ciliary body and minimal ciliary sulcus in both eyes (Fig. 1E), with
open angle and resolution of the ciliochoroidal detachment. The B
scan also showed resolution of the shallow posterior choroidal
effusion in both eyes (Fig. 1F).3. Discussion
Ciliochoroidal effusion syndrome has been documented as a
side effect of sulfonamide derivatives such as topiramate, hydro-
chlorothiazide, acetazolamide and other medications [1,9,10].
However, the pathogenesis underlying this idiosyncratic reaction of
the uveal tissues is still unknown [3,5,9]. Acetazolamide is one of
sulfa-based agents which acts as carbonic anhydrase inhibitor (CAI)
and is commonly used to reduce elevated IOP in patients with acuteowed shallow anterior chamber (A) and anterior rotation of the ciliary body with angle
(C). After treatment and resolution of ciliochoroidal effusion, repeat UBM showed deep
of the ciliary body and absence of the ciliary sulcus (E). B-scan showed resolution of
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acetazolamide-induced ciliochoroidal effusion syndrome were re-
ported presenting all after cataract surgery. Mancino et al. [3] re-
ported a case of bilateral angle-closure glaucoma (ACG) with
extensive choroidal effusion following administration of oral acet-
azolamide immediately after routine cataract extraction and
intraocular lens implantation. Malagola et al. [5] reported another
case of bilateral acute ACG with massive choroidal effusion, pos-
terior retinal folds and papillary edema following administration of
oral acetazolamide immediately after cataract surgery.
Our case is distinct from these previously reported cases with
the demonstration of plateau iris conﬁguration (PIC) by UBM after
resolution of the ciliochoroidal effusion. Clinically, there is still no
precise deﬁnition of PIC. Based on the UBM images, we propose a
taxonomy of PIC into typical and atypical anatomy based on the
angle, iris root insertion, ciliary process orientation, and ciliary
sulcus (Table 1). For typical PIC (Fig. 2B), a peripheral narrow angle
is present with a clear iris root angulation, anterior ciliary process
rotation, and absent or narrow ciliary sulcus. While in atypical PIC
(Fig. 2C), there is an open angle with the iris root inserted on top of
the ciliary process, anterior ciliary process rotation, and absent
ciliary sulcus, which is hallmark of PIC [11]. Our case represents
atypical PIC anatomy.
PIC has been initially described as an anatomical variant of iris
structure in which the peripheral iris root angulates sharply for-
ward and then centrally but the iris plane is ﬂat and the anteriorTable 1
Spectrum of anterior angle anatomy deﬁned by high resolution ultrasound biomicroscop
Normal Typical PIC
Anterior Chamber Angle Open Narrow
Iris Insertion Normal Uvea tissue and ciliary p
Ciliary Process Orientation Normal Anterior rotation
Ciliary Sulcus Present Absent
Abbreviations: PIC, plateau iris conﬁguration; PIS, plateau iris syndrome.
Fig. 2. Echography of different anterior angle anatomies. (A) Normal anatomy demonstratin
sulcus. (B) Typical plateau iris conﬁguration (PIC) anatomy demonstrating clear iris root an
junction, anterior rotation of the ciliary process, and narrow ciliary sulcus. (C) Atypical PI
cess, anterior rotation of the ciliary process and absent ciliary sulcus, which is hallmark o
insertion on the ciliary process, anterior rotation of the ciliary process, and absent ciliary schamber is assumed to be not shallow axially [11]. Additional fea-
tures include an anteriorly directed ciliary body, an absent or nar-
row ciliary sulcus, and irido-angle contact [12]. On gonioscopy, it
can be challenging to identify PIC, but the classical “double hump”
sign is a clue to the presence of PIC [13]. As in our case, UBM is
frequently used to clarify this conﬁguration and is a valuable tool
for PIC diagnosis [14].
We speculate that in PIC anatomy where there is a very narrow
or absent ciliary sulcus, the sulfa-associated swelling of anteriorly
rotated ciliary processes impinges directly on the iris root with
forward displacement of the iris. With the congested uveal tissues
of the iris diaphragm and ciliary body, there is forward movement
of the lens that contributes axial shallowing of the anterior cham-
ber. At the same time, ciliary body swelling allows for relaxation of
the lens zonules causing lens thickening and the development of
myopia [4]. Studies are in progress to determine the quantitative
biometry measurements of the ciliary sulcus, ciliary processes, and
inter-plicata distance in PIC cases versus controls. Such measure-
ments will allow us to model dynamic changes in uveal tissues and
anterior segment imaging to understand the potential role of PIC in
acute angle closure from drug-induced ciliochoroidal effusion.
A unique observation of our patient is that he had concomitant
exposure to latanoprost between two doses of acetazolamide,
which makes it difﬁcult to attribute the causative effect solely to
acetazolamide. However, during the one week course of latano-
prost, he reported no visual disturbance. His symptoms developedy.
Atypical PIC PIS
Open Closed
rocess Cliary process Uvea tissue and Ciliary process
Anterior rotation Anterior rotation
Absent Absent
g an open angle, iris root insertion at the ciliary body-sclera junction, and open ciliary
gulation with peripheral narrow angle, iris root insertion near the ciliary body-sclera
C anatomy demonstrating an open angle, iris root insertion on top of the ciliary pro-
f PIC. (D) Plateau iris syndrome demonstrating peripheral angle closure with iris root
ulcus.
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exposure to acetazolamide supports the role of this drug involved
in ciliochoroidal effusion. There are a few reports of latanoprost-
associated choroidal effusion syndrome. Sakai et al. [15] reported
a drug-induced ciliochoroidal effusion in a patient with Sturge-
Weber syndrome. They postulated that interaction of the
enhanced uveoscleral outﬂow with latanoprost adjunctive with
elevated episcleral venous pressure may have caused the conges-
tion of the aqueous humor in the supraciliary-choroidal space,
resulting in the ciliochoroidal effusion. Alimgil and Benian [16]
reported choroidal effusion and shallow anterior chamber after
adjunctive therapy with latanoprost in a patient who had trabe-
culectomy for angle closure glaucoma. In contrast to these two
cases, our patient has healthy eyes and we cannot conclude with
certainty the role of latanoprost in the pathogenesis of choroidal
effusion syndrome in our patient.4. Conclusion
We propose a taxonomy classiﬁcation of the anterior segment
relevant to the angle, iris insertion, ciliary process orientation, and
ciliary sulcus. This well-documented case of atypical PIC suggests a
potential anatomical risk to develop acute angle closure in
acetazolamide-induced ciliochoroidal effusion syndrome. Although
these cases are rare, clinicians are encouraged to continue ultra-
sound imaging at the time of the episode and after resolution to
determine if such anatomy is a possible factor underlying this
adverse reaction.Acknowledgements
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